C07J 5/0053
Not substituted in position 16
Official title: {not substituted in position 16}
C07J5/0053 (Not substituted in position 16) appears on 216 US grants and 128 published applications in this corpus.
Search patents in C07J- Granted patents
- 216
- Published applications
- 128
- Assignees
- 82
- Inventors
- 338
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 4 | 0 |
| 1980 | 9 | 0 |
| 1981 | 9 | 0 |
| 1982 | 12 | 0 |
| 1983 | 5 | 0 |
| 1984 | 8 | 0 |
| 1985 | 6 | 0 |
| 1986 | 14 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 2 |
| 2004 | 2 | 1 |
| 2005 | 2 | 3 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 2 | 3 |
| 2011 | 1 | 2 |
| 2012 | 3 | 3 |
| 2013 | 1 | 11 |
| 2014 | 7 | 9 |
| 2015 | 6 | 7 |
| 2016 | 7 | 15 |
| 2017 | 8 | 8 |
| 2018 | 6 | 5 |
| 2019 | 10 | 8 |
| 2020 | 4 | 8 |
| 2021 | 4 | 4 |
| 2022 | 5 | 9 |
| 2023 | 3 | 5 |
| 2024 | 3 | 6 |
| 2025 | 7 | 7 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids19 May 2026US 12,630,853 B2Euroapi France
- Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products18 Nov 2025US 12,473,247 B2
- Modified glucocorticoids9 Sep 2025US 12,410,209 B2Board of Regents, The University of Texas System
- Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives24 Jun 2025US 12,337,002 B2Cassiopea S.P.A.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- Non-hormonal steroid modulators of nf-kb for treatment of disease3 Sep 2026US 2026/0256810 A1ReveraGen BioPharma, Inc.
- Cocrystals of cortexolone 17-propionate and methods for their preparation6 Aug 2026US 2026/0226092 A1Farmabios S.P.A.
- Modified glucocorticoids30 Jul 2026US 2026/0217754 A1Board of Regents, The University of Texas System
- Process For The Production Of 21-(Acetyloxy)-17-(Propionyloxy)-Pregn-4-Ene-3,20-Dione4 Jun 2026US 2026/0152524 A1Industriale Chimica S.R.L.
- Pralatrexate and cop combination for the treatment of patients with peripheral t cell lymphoma14 May 2026US 2026/0130919 A1Acrotech Biopharma Inc.
Most cited
By later US patents
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003
- Fatty acid esters as bioactive compounds147US 6,245,811 B1Scotia Holdings PLC · 2001
- Methods for controlling ocular hypertension with angiostatic steroids86US 4,876,250 AAlcon Laboratories, Inc. · 1989
- Angiostatic steroids and methods and compositions for controlling ocular hypertension78US 5,371,078 AAlcon Laboratories, Inc. · 1994
- Use of angiostatic steroids in photodynamic therapy75US 6,297,228 B1Alcon Manufacturing, Ltd. · 2001